CareRx Corp. buy krebskrebs
Start price
13.06.23
/
50%
€1.59
Target price
13.06.24
€2.00
Performance (%)
-13.21%
End price
14.06.24
€1.38
Summary
This prediction ended on 14.06.24 with a price of €1.38. The price of CareRx Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.21%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CareRx Corp. | 0.000% | 0.000% | 14.444% | 41.096% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by krebskrebs for this prediction
In the thread CareRx Corp. diskutieren
Buy mit Kursziel 2,0
In the thread Trading CareRx Corp.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

